Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 28:16:1595-1605.
doi: 10.2147/IJWH.S477476. eCollection 2024.

From Awareness to Action: Pioneering Solutions for Women's UTI Challenges in the Era of Precision Medicine

Affiliations

From Awareness to Action: Pioneering Solutions for Women's UTI Challenges in the Era of Precision Medicine

Emery Haley et al. Int J Womens Health. .

Abstract

This article aims to bring clinicians' awareness to the widespread impact of urinary tract infection (UTI) on the lives of women and to the advances that offer hope for future improvements in the diagnosis and management of UTI. Thanks to physiological, anatomical, and lifestyle factor differences, women face heightened vulnerability to UTIs compared to men. In fact, women are four times more likely than men to develop a UTI and around half of these women encounter UTI recurrence, which is a significant source of both physical and psychosocial burdens. Despite the current shortcomings in diagnosis and management, emerging diagnostic technologies promise to identify UTIs more accurately and rapidly, offering women hope for a revolution in UTI management. Meanwhile, clinicians have the opportunity to reduce the psychosocial burden by recognizing the value of patients' lived experiences and ensuring their care plan is in alignment with their patients' goals and expectations for medical care.

Keywords: mass spectrometry; metagenomic next-generation sequencing; multiplex-polymerase chain reaction; urinary tract infection; urine culture; women’s health.

PubMed Disclaimer

Conflict of interest statement

Luke reports patents (11,053,532, 10/160,991, and 11,746,371) licensed to Pathnostics; patents (18,351,286, 18,351,385, 17,830,227, 18,451,748, 17,178,091) pending to Pathnostics and both Haley and Luke are employees of Pathnostics which offers the Guidance UTI test for diagnosis and the determination of treatment options for those with complicated or recurrent UTI’s. The authors report no other conflicts of interest in this work.

References

    1. Kolman KB. Cystitis and Pyelonephritis Diagnosis, Treatment, and Prevention. Prim Care. 2019;46(2):191–202. doi:10.1016/j.pop.2019.01.001 - DOI - PubMed
    1. Trautner BW. Urinary tract infection as a continuum—implications for diagnostic and antibiotic stewardship. Clin Infect Dis. 2020;72(8):1339–1341. doi:10.1093/cid/ciaa280 - DOI - PubMed
    1. Larsen AW, Chen Y, Crandall KA, Icenhour CR, Valencia CA. Characterization of the Interstitial Cystitis/Bladder Pain Syndrome Microbiome in Clinically Diagnosed Patients. Clin Immunol Res. 2022;6(2). doi:10.33425/2639-8494.1047 - DOI
    1. Adelugba I, Siddiqui S, Aziz A, De EJB, Wolff G. Interstitial Cystitis/Bladder Pain Syndrome: what Today’s Urologist Should Know. Curr Bl Dysfunct Rep. 2023;18(1):16–28. doi:10.1007/s11884-022-00676-1 - DOI
    1. Colgan R, Nicolle LE, McGlone A, Hooton TM. Asymptomatic bacteriuria in adults. Am Fam Physician. 2006;74(6):985–990. - PubMed

LinkOut - more resources